167 related articles for article (PubMed ID: 22589419)
1. Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.
Grabus SD; Carroll FI; Damaj MI
Nicotine Tob Res; 2012 Nov; 14(11):1356-61. PubMed ID: 22589419
[TBL] [Abstract][Full Text] [Related]
2. Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Malcolm E; Carroll FI; Blough B; Damaj MI; Shoaib M
Psychopharmacology (Berl); 2015 Aug; 232(15):2763-71. PubMed ID: 25761841
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
Lukas RJ; Muresan AZ; Damaj MI; Blough BE; Huang X; Navarro HA; Mascarella SW; Eaton JB; Marxer-Miller SK; Carroll FI
J Med Chem; 2010 Jun; 53(12):4731-48. PubMed ID: 20509659
[TBL] [Abstract][Full Text] [Related]
4. Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
Damaj MI; Grabus SD; Navarro HA; Vann RE; Warner JA; King LS; Wiley JL; Blough BE; Lukas RJ; Carroll FI
J Pharmacol Exp Ther; 2010 Sep; 334(3):1087-95. PubMed ID: 20576796
[TBL] [Abstract][Full Text] [Related]
5. CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.
Zhu AZ; Cox LS; Nollen N; Faseru B; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2012 Dec; 92(6):771-7. PubMed ID: 23149928
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-like discriminative stimulus effects of bupropion in rats.
Wiley JL; Lavecchia KL; Martin BR; Damaj MI
Exp Clin Psychopharmacol; 2002 May; 10(2):129-35. PubMed ID: 12022798
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
[TBL] [Abstract][Full Text] [Related]
8. Nicotine and bupropion share a similar discriminative stimulus effect.
Young R; Glennon RA
Eur J Pharmacol; 2002 May; 443(1-3):113-8. PubMed ID: 12044800
[TBL] [Abstract][Full Text] [Related]
9. Bupropion and bupropion analogs as treatments for CNS disorders.
Carroll FI; Blough BE; Mascarella SW; Navarro HA; Lukas RJ; Damaj MI
Adv Pharmacol; 2014; 69():177-216. PubMed ID: 24484978
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Damaj MI; Slemmer JE; Carroll FI; Martin BR
J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
[TBL] [Abstract][Full Text] [Related]
11. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Semba J; Wakuta M
Psychiatry Clin Neurosci; 2008 Aug; 62(4):435-41. PubMed ID: 18778441
[TBL] [Abstract][Full Text] [Related]
12. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Rauhut AS; Dwoskin LP; Bardo MT
Nicotine Tob Res; 2005 Dec; 7(6):901-7. PubMed ID: 16298725
[TBL] [Abstract][Full Text] [Related]
13. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
Biala G; Kruk M
J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
[TBL] [Abstract][Full Text] [Related]
14. Bupropion is a nicotinic antagonist.
Slemmer JE; Martin BR; Damaj MI
J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
[TBL] [Abstract][Full Text] [Related]
15. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
16. A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Hansard MJ; Jackson MJ; Smith LA; Rose S; Jenner P
Behav Pharmacol; 2011 Jun; 22(3):269-74. PubMed ID: 21522056
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.
Pandhare A; Pappu AS; Wilms H; Blanton MP; Jansen M
Neuropharmacology; 2017 Feb; 113(Pt A):89-99. PubMed ID: 27671323
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
Banks ML; Smith DA; Blough BE
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):196-203. PubMed ID: 26886209
[TBL] [Abstract][Full Text] [Related]
19. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
Stuebler AG; Jansen M
Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
[TBL] [Abstract][Full Text] [Related]
20. Effect of bupropion on nicotine self-administration in rats.
Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
